JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

Clinical trial NCT04892173 · RECRUITING

Trial details

NCT number: NCT04892173
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell

Start date: 2021-12-10
Primary completion: 2028-06-30
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.